Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X

Find Lucidinprimeveroside manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

EU WC

EU WC

0

Listed Suppliers

Listed Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Lucidinprimeveroside
Also known as: Lucidin primeveroside, 29706-59-0, Lucidin 3-o-primeveroside, 1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione, Lucidin 3-o-beta-primveroside, 1-hydroxy-2-(hydroxymethyl)-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2s,3r,4s,5r)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)anthracene-9,10-dione
Molecular Formula
C26H28O14
Molecular Weight
564.5  g/mol
InChI Key
NVKNRXOMCYTFJF-WFLOGZPDSA-N

1-hydroxy-2-(hydroxymethyl)-3-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxan-2-yl]oxy}anthracene-9,10-dione is a natural product found in Rubia argyi, Rubia yunnanensis, and other organisms with data available.
1 2D Structure

Lucidinprimeveroside

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-hydroxy-2-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione
2.1.2 InChI
InChI=1S/C26H28O14/c27-6-12-14(5-11-16(19(12)31)18(30)10-4-2-1-3-9(10)17(11)29)39-26-24(36)22(34)21(33)15(40-26)8-38-25-23(35)20(32)13(28)7-37-25/h1-5,13,15,20-28,31-36H,6-8H2/t13-,15-,20+,21-,22+,23-,24-,25+,26-/m1/s1
2.1.3 InChI Key
NVKNRXOMCYTFJF-WFLOGZPDSA-N
2.1.4 Canonical SMILES
C1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(C(=C4C(=C3)C(=O)C5=CC=CC=C5C4=O)O)CO)O)O)O)O)O)O
2.1.5 Isomeric SMILES
C1[C@H]([C@@H]([C@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(C(=C4C(=C3)C(=O)C5=CC=CC=C5C4=O)O)CO)O)O)O)O)O)O
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Lucidin 3-o-beta-primveroside

2. Lucidin 3-o-primveroside

2.2.2 Depositor-Supplied Synonyms

1. Lucidin Primeveroside

2. 29706-59-0

3. Lucidin 3-o-primeveroside

4. 1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione

5. Lucidin 3-o-beta-primveroside

6. 1-hydroxy-2-(hydroxymethyl)-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2s,3r,4s,5r)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)anthracene-9,10-dione

7. 9,10-anthracenedione, 1-hydroxy-2-(hydroxymethyl)-3-[(6-o-beta-d-xylopyranosyl-beta-d-glucopyranosyl)oxy]-

8. Ccris 4532

9. Lucidin 3-o-primveroside

10. Lucidin Primevoroside

11. Lucidin-primeveroside

12. Chembl521217

13. Schembl23522435

14. Dtxsid40952155

15. Hy-n8022

16. Zinc42878492

17. Glucopyranoside, 4-hydroxy-3-(hydroxymethyl)-2-anthraquinonyl 6-o-beta-d- Xylopyranosyl-, Beta-d-

18. Cs-0138995

19. E88947

20. 1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxytetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-anthracene-9,10-dione

21. 4-hydroxy-3-(hydroxymethyl)-9,10-dioxo-9,10-dihydroanthracen-2-yl 6-o-pentopyranosylhexopyranoside

22. Ncgc00384986-01!1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione

2.3 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 564.5 g/mol
Molecular Formula C26H28O14
XLogP3-2.1
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count14
Rotatable Bond Count6
Exact Mass564.14790556 g/mol
Monoisotopic Mass564.14790556 g/mol
Topological Polar Surface Area233 Ų
Heavy Atom Count40
Formal Charge0
Complexity918
Isotope Atom Count0
Defined Atom Stereocenter Count9
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY